Provided by Tiger Fintech (Singapore) Pte. Ltd.

Agree

76.45
-0.5700-0.74%
Volume:608.25K
Turnover:46.45M
Market Cap:8.18B
PE:42.95
High:77.16
Open:76.79
Low:75.95
Close:77.02
Loading ...

Agree Realty to Pay Monthly Dividend of $0.253 a Share, Payable April 14 to Holders of Record March 31

MT Newswires Live
·
12 Mar

Agree Realty Declares Monthly Common and Preferred Dividends

THOMSON REUTERS
·
12 Mar

Press Release: Agree Realty Declares Monthly Common and Preferred Dividends

Dow Jones
·
12 Mar

PDS Biotech Leadership to Participate in March Conferences

GlobeNewswire
·
11 Mar

Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update

GlobeNewswire
·
11 Mar

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency's (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

Business Wire
·
11 Mar

Agree Realty Is Maintained at Overweight by Wells Fargo

Dow Jones
·
10 Mar

Is Pfizer Inc. (PFE) the Most Undervalued US Stock to Buy According to Hedge Funds?

Insider Monkey
·
10 Mar

Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC

Business Wire
·
10 Mar

Veren, Whitecap Agree on $10.4 Billion Business Combination in All-Share Transaction

MT Newswires Live
·
10 Mar

LTRN: M&A Illuminates GBM Value

Zacks Small Cap Research
·
10 Mar

CytomX Therapeutics, Inc. (CTMX): Among the Cheap Growth Stocks to Buy Now

Insider Monkey
·
08 Mar

PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune® HPV in HPV16-Positive Head and Neck Cancer

GlobeNewswire
·
07 Mar

CStone Pharmaceuticals Submit Clinical Trial Application in Australia for Cancer Drug

MT Newswires Live
·
06 Mar

Astellas and YASKAWA Agree to Establish a Joint Venture Focused on Cell Therapy Manufacturing

PR Newswire
·
06 Mar

Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire
·
06 Mar